Cyclophosphamide Therapy in the Management of Nephrotic Syndrome
摘要
In conclusion, while CP has historically been a cornerstone in the treatment of nephrotic syndrome, its role is evolving amidst the advent of novel therapeutic options. Ongoing research and clinical trials will be crucial in elucidating its place in the treatment paradigm, ensuring that we continue to optimize care for patients with this challenging condition.